Supplementary 25 26

Methods 27
Additional cell lines and bacterial strain 28
The human hepatic cell line HepG2 (a kind gift from Ute Albrecht, University 29 of Duesseldorf, Germany) was cultivated in DMEM/F-12 medium 1:1. The 30 human monocytic cell line THP-1 was cultivated in RPMI 1640 with 1% 31 glutamine. The murine lewis lung carcinoma (LLC) and mouse embryonic 32 fibroblast (MEF) cell lines were cultivated in DMEM. Each medium was 33 supplemented with 10% FBS. Primary human umbilical vein endothelial cells 34 (HUVEC) were cultivated in endothelial cell growth medium with supplement 35 mix (PromoCell, Heidelberg, Germany). 36
THP-1 cells (6-well: 2×10
6 , 12-well: 1×10 6 ) were stimulated with 10 ng ml -1
37
phorbol-12-myristate-13-acetate (PMA, AppliChem, Darmstadt, Germany) for 38 differentiation into macrophages 16 h prior to infection. LLC (6-well: 0.3×10 6 ) 39
and MEF cells (6-well: 0.25×10 6 ) were seeded 16 h and HUVECs (6-well: 40 0.5×10 6 ) were seeded 48 h prior to infection. During infection culture medium 41 supplemented as indicated in the method section was used. 42
The mouse-adapted S. aureus strain LS1 was cultivated as described in the 43 method section. 44
45
Plaque assay 46
Standard plaque titration was performed as described earlier 50 . 47
48
Transfer of conditioned medium 49
HepG2 cells (12-well: 0.3×10 6 ) were seeded in 1 ml culture medium 40 h prior 50 to stimulation. Calu-3 cells were infected as described in the method section. 51
Supernatants of three 6-wells were pooled and sterile filtrated with a 0.2 µm 52 filter to avoid transfer of living pathogens. HepG2 cells were washed and 53 stimulated with 800 µl conditioned medium for 20 h at 37°C, 5% CO 2 . 54 55
Actinomycin D treatment 56
A549 cells were infected with IV H1N1(M) (MOI 5) and S. aureus 6850 (MOI 57 50) as described in the material and method section. At 6 h p.i. cells were 58 lysed, or washed and incubated in 1 ml of DMEM/BA supplemented with 1 µg 59 ml -1 actinomycin D (Santa Cruz Biotechnology, Dallas, USA) for further 0.5, 1 60 or 2 h at 37°C, 5% CO 2 . Cells were lysed and total cellular RNA was isolated 61 as described in the method section. For investigation of IL-6 mRNA stability, 62 the amount of IL-6 mRNA was measured for each time point indicated by RT-63 qPCR and IL-6 levels were compared to untreated cells (0 h). shown. Samples, which were treated with conditioned medium of IV-infected 83
Calu-3 cells, were arbitrarily set 100%. After normalisation, one-way ANOVA 84 followed by Dunnett's multiple comparison tests were used to compare mock 85 and IV and/or S. aureus infected samples (* p < 0.05). 
